Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Int J Cancer. 2018 Mar 8;143(3):515–526. doi: 10.1002/ijc.31335

Figure 1. Box and whisker plots showing serum levels of CA125, and antibody titers against CTAG1A, GTAG2, NUDT11 and P53, for ovarian cancer cases and matched controls, by intervals of time prior to diagnosis.

Figure 1

Figure 1

Figure 1

Reference lines are drawn at levels of the markers’ 95% and 98% specificity in all controls.